In 2017, the U.S. Food and Drug Administration approved 47 new cancer drugs; 38 of them were tested right here in Sarasota. In 2014, the FDA approved the first two drugs for idiopathic pulmonary fibrosis (IPF), a devastating lung disease with an average post-diagnosis lifespan of about 3.5 years. In Sarasota, IPF patients have had access to one of those treatments since 2002, and the other since 2010. Some Sarasota-treated IPF patients have lived more than 10 years.
These aren’t the only examples of local drug trials. Our region’s medical ecosystem supports a robust clinical trials industry, where doctors provide local patients and patients from around the state and the Southeastern U.S. with access to promising new treatments for cancer to dementia to wrinkles.
“When most people think of clinical research, they think of wet lab research where you’ve got test tubes and microscopes,” says Dr. Kirk Voelker, medical director for the Clinical Research Center at Sarasota Memorial Health Care System. “That’s not what we do. We do clinical trials. A drug or device company will set up a clinical trial through the FDA for a promising new drug or device, and we’ll be one of the sites. There might be between 10 and 50 sites in the U.S. [for any given trial].”
The purpose, he says, is not to invent something, but “to bring something that has promise to Sarasota years before it is released.”
When pirfenidone, which had been tested here since 2002, was approved by the FDA in 2014, IPF patients from as far away as Kentucky and Philadelphia came to Sarasota to participate in an expanded access trial at SMH. Some people are referred by their doctors or a nonprofit organization; others find trials via clinicaltrials.gov, a National Institutes of Health website listing all clinical trials in the country.
Individual doctors also develop their own relationships with certain drug or device companies. More than 600 studies are currently underway in Sarasota-Manatee, in the wake of thousands that have been completed here in the past.
Local doctors benefit from local clinical research centers—generally found in larger academic institutions—that provide support and infrastructure for navigating paperwork and regulations. SMH’s Clinical Trials Center, a rarity for a community hospital, represents the hospital’s ambitions for drawing world-class doctors to serve patients here. “The physician can do what they’re good at, and we do everything else to support them,” says Voelker.
Southwest Florida’s older, health-savvy community is suited for trials for treatments targeting conditions that affect seniors. At any given moment, SMH’s center may be conducting trials involving pulmonary or cardiovascular conditions, aortic aneurism stents, heart failure devices or hernia repair.
Florida Cancer Specialists, which led local trials involving those 38 oncological drugs approved last year, is part of the Nashville, Tenn.-based Sarah Cannon Research Institute, among the largest clinical research organizations in the country. When Sarah Cannon partners decide to participate in an early-phase cancer trial that suits Florida’s older population, then that trial is coming to Sarasota. FCS’s Sarasota center may be one of only three or four sites in the country participating in certain trials. “It could be us, M.D. Anderson in Houston, Sloan Kettering in New York, and Dana Farber in Boston,” says Dr. Manish Patel, a principal investigator for FCS’s Drug Development Unit.
FCS located its Drug Development Unit in Sarasota in 2011 in part because of convenient geography: Its 100-plus offices span Fort Lauderdale to Tallahassee.
About 240 new patients every year participate in about 50 ongoing Phase 1 clinical trials at the unit. One of the many recent cancer drug approvals, Avelumab, which was tested there, represents oncology’s current focus on immunotherapies.
Voelker and his peers emphasize the importance of Institutional Review Boards, which monitor all aspects of a trial to ensure accurate, scientifically sound results. And while the research centers seek out the most promising trials and recruit patients who best suit the treatment, doctors caution patients to manage expectations. “If I were to say, ‘This [hypothetical trial treatment] is going to help people,’ that’s overstepping my bounds, because we don’t know it,” Voelker says. “That’s why we’re doing the clinical trial.”
Regional clinical trials are recruiting patients right now.
Clinical trials are key to advances in preventing, detecting and treating diseases. In Sarasota and Manatee, 242 trials were recruiting healthy volunteers and individuals with diseases and illnesses. We’ve listed a few being conducted by our Top Docs. For patient criteria and more information on these and other trials, visit clinicaltrials.gov; to learn what it’s like to be a volunteer, go to National Institutes of Health.
Treatment of Aortic Aneurysms
Sarasota Memorial Hospital is testing a device that allows doctors to treat challenging abdominal aortic aneurysms (AAA) through an endovascular approach, rather than more invasive abdominal surgery.
Local site/investigator: Sarasota Vascular Specialists, Dr. Michael Lepore
Sponsor: W.L. Gore & Associates
Sponsor contact: Arthur Scott, (623) 234-5263, [email protected]
Sleep Drug to Benefit Mild Alzheimer’s Disease Patients
The Roskamp Institute is one of 72 sites testing Piromelatine, a multimodal sleep drug that “may improve memory, other types of cognition, and mood, in part by improving sleep quality in people with mild Alzheimer’s dementia,” according to the National Institute on Aging.
Local site: The Roskamp Institute
Sponsor: Neurim Pharmaceuticals (Israel)
Sponsor contact: [email protected]
The Use of J-Plasma for Dermal Resurfacing
This study evaluates the safety and effectiveness of J-Plasma, an energy device that uses cold helium plasma with radio waves to reduce facial wrinkles.
Local site/investigator: Institute for Integrated Aesthetics, Dr. J. David Holcomb
Sponsor: Bovie Medical Corporation
Sponsor contact: Cindy Ponce, (770) 367-8173, [email protected]
Testing a New Substance for Patients with Solid Tumors
BI 754091 is a new “immune checkpoint inhibitor” designed to rally a patient’s own immune system—which is often suppressed by the tumor—to fight cancer, according CenterWatch. The trial is to determine the safe dosage and tolerability in patients with solid tumors.
Local site: Florier Specialists
Sponsor: Boehringer Ingelheim
Sponsor contact: (800) 243-0127, [email protected]
Investigating an Artificial Disc to Alleviate Neck Pain
This trial tests the Simplify® Cervical Artificial Disc for people with cervical degenerative disc disease, a common cause of neck pain that can continue down the arm. The study is testing the safety and effectiveness of this device versus other procedures.
Local site: Kennedy White Orthopedic Center
Sponsor: Simplify Medical
Sponsor contact: Kelsey Welch, (888) 505-3404, [email protected]
Studying the Effects of Iron Therapy as a Treatment for Heart Failure
Iron deficiency has been identified as an issue in chronic heart failure. This is a study to assess the effects of IV Ferric Carboxymaltose (FCM) for patients in heart failure with iron deficiency.
Local site/investigator: Cardiovascular & Vein Center of Florida (Bradenton),
Sponsor: Luitpold Pharmaceuticals
Sponsor contact: Todd Koch, (610) 650-4200, [email protected]
National research group Castle Connolly Medical compiles lists of top doctors all across the United States, soliciting nominations from physicians and other medical professionals and examining nominees’ credentials and career histories, from education and board certifications to procedure volumes and outcomes. Doctors cannot nominate themselves, and they do not—and cannot—pay to be included on the list. To see our list, visit sarasotamagazine.com/doctors. While the physicians listed are among the very best in our area, we know that choosing the right doctor for you is a personal choice based on more than rankings. We hope this list provides a useful starting point and reference when you are in search of the health care you need.